Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)

计划入组 50 人 · 首次发布于 2013 年 4 月 12 日

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

计划入组 608 人 · 首次发布于 2022 年 9 月 2 日

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

计划入组 85 人 · 首次发布于 2000 年 12 月 7 日

RES-020

RES-3105

RES-420

AURONOVA RES INC

United States

RFS Pharma, LLC

United States

Ono Pharma Partners with Aitia to Use Causal AI Digital Twins for Neurological Drug Discovery

Aitia Partners with Gustave Roussy to Develop AI-Powered Digital Twins for Cancer Research

FDA Advisory Committee Recommends Dismantling Clozapine REMS Program